id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3771-0004,FDA,FDA-2018-N-3771,Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request,Notice,Notice of Availability,2020-10-21T04:00:00Z,2020,10,2020-10-21T04:00:00Z,2020-12-22T04:59:59Z,2020-12-19T02:01:52Z,2020-23290,0,0,090000648491f0d0
FDA-2018-N-3771-0005,FDA,FDA-2018-N-3771,"Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989
Guidance for Industry",Other,Guidance,2020-10-21T04:00:00Z,2020,10,2020-10-21T04:00:00Z,,2023-09-15T14:11:15Z,,0,0,090000648491f204
FDA-2018-N-3771-0003,FDA,FDA-2018-N-3771,"Report on the Performance of Drug and Biologics Firms in Conducting
Postmarketing Requirements and Commitments; Availability",Notice,Notice of Availability,2020-08-06T04:00:00Z,2020,8,2020-08-06T04:00:00Z,,2020-08-06T13:19:04Z,2020-17113,0,0,09000064847dd043